Global Pentavalent Vaccine Market Growth 2026-2032
The global Pentavalent Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
A pentavalent vaccine is a five-in-one vaccine that protects against diphtheria, tetanus, and whooping cough, hepatitis B, and Haemophilus influenza type b with just one dosage. One of the most well-known and successful techniques of preventing paediatric diseases is vaccination. The Government of India has achieved tremendous progress in preventing and controlling vaccine-preventable diseases since implementing the Universal Immunization Programme (UIP) (VPDs). The introduction of a pentavalent vaccination will help to minimise the number of cases of pneumonia and meningitis caused by the germs Haemophilus influenzae type b (Hib).
United States market for Pentavalent Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Pentavalent Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Pentavalent Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Pentavalent Vaccine players cover Serum Institute of India, Panacea Drugs Pvt. Ltd, Shantha Biotechnics, Biological E. Ltd., Novartis AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Pentavalent Vaccine Industry Forecast? looks at past sales and reviews total world Pentavalent Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Pentavalent Vaccine sales for 2026 through 2032. With Pentavalent Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pentavalent Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Pentavalent Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pentavalent Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pentavalent Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pentavalent Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pentavalent Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pentavalent Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
A pentavalent vaccine is a five-in-one vaccine that protects against diphtheria, tetanus, and whooping cough, hepatitis B, and Haemophilus influenza type b with just one dosage. One of the most well-known and successful techniques of preventing paediatric diseases is vaccination. The Government of India has achieved tremendous progress in preventing and controlling vaccine-preventable diseases since implementing the Universal Immunization Programme (UIP) (VPDs). The introduction of a pentavalent vaccination will help to minimise the number of cases of pneumonia and meningitis caused by the germs Haemophilus influenzae type b (Hib).
United States market for Pentavalent Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Pentavalent Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Pentavalent Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Pentavalent Vaccine players cover Serum Institute of India, Panacea Drugs Pvt. Ltd, Shantha Biotechnics, Biological E. Ltd., Novartis AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Pentavalent Vaccine Industry Forecast? looks at past sales and reviews total world Pentavalent Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Pentavalent Vaccine sales for 2026 through 2032. With Pentavalent Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pentavalent Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Pentavalent Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pentavalent Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pentavalent Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pentavalent Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pentavalent Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pentavalent Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Lyophilized
- Liquid
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Serum Institute of India
- Panacea Drugs Pvt. Ltd
- Shantha Biotechnics
- Biological E. Ltd.
- Novartis AG
- Crucell
- Bio Farma
- What is the 10-year outlook for the global Pentavalent Vaccine market?
- What factors are driving Pentavalent Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Pentavalent Vaccine market opportunities vary by end market size?
- How does Pentavalent Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pentavalent Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pentavalent Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pentavalent Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Pentavalent Vaccine Segment by Type
2.2.1 Lyophilized
2.2.2 Liquid
2.2.3 Pentavalent Vaccine Sales by Type
2.2.3.1 Global Pentavalent Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Pentavalent Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Pentavalent Vaccine Sale Price by Type (2021-2026)
2.3 Pentavalent Vaccine Segment by Application
2.3.1 Retail Pharmacy
2.3.2 Hospital Pharmacy
2.3.3 E-commerce
2.3.4 Pentavalent Vaccine Sales by Application
2.3.4.1 Global Pentavalent Vaccine Sale Market Share by Application (2021-2026)
2.3.4.2 Global Pentavalent Vaccine Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Pentavalent Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pentavalent Vaccine Breakdown Data by Company
3.1.1 Global Pentavalent Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Pentavalent Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Pentavalent Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Pentavalent Vaccine Revenue by Company (2021-2026)
3.2.2 Global Pentavalent Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Pentavalent Vaccine Sale Price by Company
3.4 Key Manufacturers Pentavalent Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pentavalent Vaccine Product Location Distribution
3.4.2 Players Pentavalent Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PENTAVALENT VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Pentavalent Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Pentavalent Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pentavalent Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pentavalent Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Pentavalent Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pentavalent Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pentavalent Vaccine Sales Growth
4.4 APAC Pentavalent Vaccine Sales Growth
4.5 Europe Pentavalent Vaccine Sales Growth
4.6 Middle East & Africa Pentavalent Vaccine Sales Growth
5 AMERICAS
5.1 Americas Pentavalent Vaccine Sales by Country
5.1.1 Americas Pentavalent Vaccine Sales by Country (2021-2026)
5.1.2 Americas Pentavalent Vaccine Revenue by Country (2021-2026)
5.2 Americas Pentavalent Vaccine Sales by Type (2021-2026)
5.3 Americas Pentavalent Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pentavalent Vaccine Sales by Region
6.1.1 APAC Pentavalent Vaccine Sales by Region (2021-2026)
6.1.2 APAC Pentavalent Vaccine Revenue by Region (2021-2026)
6.2 APAC Pentavalent Vaccine Sales by Type (2021-2026)
6.3 APAC Pentavalent Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pentavalent Vaccine by Country
7.1.1 Europe Pentavalent Vaccine Sales by Country (2021-2026)
7.1.2 Europe Pentavalent Vaccine Revenue by Country (2021-2026)
7.2 Europe Pentavalent Vaccine Sales by Type (2021-2026)
7.3 Europe Pentavalent Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pentavalent Vaccine by Country
8.1.1 Middle East & Africa Pentavalent Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pentavalent Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Pentavalent Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Pentavalent Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pentavalent Vaccine
10.3 Manufacturing Process Analysis of Pentavalent Vaccine
10.4 Industry Chain Structure of Pentavalent Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pentavalent Vaccine Distributors
11.3 Pentavalent Vaccine Customer
12 WORLD FORECAST REVIEW FOR PENTAVALENT VACCINE BY GEOGRAPHIC REGION
12.1 Global Pentavalent Vaccine Market Size Forecast by Region
12.1.1 Global Pentavalent Vaccine Forecast by Region (2027-2032)
12.1.2 Global Pentavalent Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pentavalent Vaccine Forecast by Type (2027-2032)
12.7 Global Pentavalent Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Serum Institute of India
13.1.1 Serum Institute of India Company Information
13.1.2 Serum Institute of India Pentavalent Vaccine Product Portfolios and Specifications
13.1.3 Serum Institute of India Pentavalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Serum Institute of India Main Business Overview
13.1.5 Serum Institute of India Latest Developments
13.2 Panacea Drugs Pvt. Ltd
13.2.1 Panacea Drugs Pvt. Ltd Company Information
13.2.2 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product Portfolios and Specifications
13.2.3 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Panacea Drugs Pvt. Ltd Main Business Overview
13.2.5 Panacea Drugs Pvt. Ltd Latest Developments
13.3 Shantha Biotechnics
13.3.1 Shantha Biotechnics Company Information
13.3.2 Shantha Biotechnics Pentavalent Vaccine Product Portfolios and Specifications
13.3.3 Shantha Biotechnics Pentavalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Shantha Biotechnics Main Business Overview
13.3.5 Shantha Biotechnics Latest Developments
13.4 Biological E. Ltd.
13.4.1 Biological E. Ltd. Company Information
13.4.2 Biological E. Ltd. Pentavalent Vaccine Product Portfolios and Specifications
13.4.3 Biological E. Ltd. Pentavalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Biological E. Ltd. Main Business Overview
13.4.5 Biological E. Ltd. Latest Developments
13.5 Novartis AG
13.5.1 Novartis AG Company Information
13.5.2 Novartis AG Pentavalent Vaccine Product Portfolios and Specifications
13.5.3 Novartis AG Pentavalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Novartis AG Main Business Overview
13.5.5 Novartis AG Latest Developments
13.6 Crucell
13.6.1 Crucell Company Information
13.6.2 Crucell Pentavalent Vaccine Product Portfolios and Specifications
13.6.3 Crucell Pentavalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Crucell Main Business Overview
13.6.5 Crucell Latest Developments
13.7 Bio Farma
13.7.1 Bio Farma Company Information
13.7.2 Bio Farma Pentavalent Vaccine Product Portfolios and Specifications
13.7.3 Bio Farma Pentavalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Bio Farma Main Business Overview
13.7.5 Bio Farma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pentavalent Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pentavalent Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pentavalent Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Pentavalent Vaccine Segment by Type
2.2.1 Lyophilized
2.2.2 Liquid
2.2.3 Pentavalent Vaccine Sales by Type
2.2.3.1 Global Pentavalent Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Pentavalent Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Pentavalent Vaccine Sale Price by Type (2021-2026)
2.3 Pentavalent Vaccine Segment by Application
2.3.1 Retail Pharmacy
2.3.2 Hospital Pharmacy
2.3.3 E-commerce
2.3.4 Pentavalent Vaccine Sales by Application
2.3.4.1 Global Pentavalent Vaccine Sale Market Share by Application (2021-2026)
2.3.4.2 Global Pentavalent Vaccine Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Pentavalent Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pentavalent Vaccine Breakdown Data by Company
3.1.1 Global Pentavalent Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Pentavalent Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Pentavalent Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Pentavalent Vaccine Revenue by Company (2021-2026)
3.2.2 Global Pentavalent Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Pentavalent Vaccine Sale Price by Company
3.4 Key Manufacturers Pentavalent Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pentavalent Vaccine Product Location Distribution
3.4.2 Players Pentavalent Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PENTAVALENT VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Pentavalent Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Pentavalent Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pentavalent Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pentavalent Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Pentavalent Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pentavalent Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pentavalent Vaccine Sales Growth
4.4 APAC Pentavalent Vaccine Sales Growth
4.5 Europe Pentavalent Vaccine Sales Growth
4.6 Middle East & Africa Pentavalent Vaccine Sales Growth
5 AMERICAS
5.1 Americas Pentavalent Vaccine Sales by Country
5.1.1 Americas Pentavalent Vaccine Sales by Country (2021-2026)
5.1.2 Americas Pentavalent Vaccine Revenue by Country (2021-2026)
5.2 Americas Pentavalent Vaccine Sales by Type (2021-2026)
5.3 Americas Pentavalent Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pentavalent Vaccine Sales by Region
6.1.1 APAC Pentavalent Vaccine Sales by Region (2021-2026)
6.1.2 APAC Pentavalent Vaccine Revenue by Region (2021-2026)
6.2 APAC Pentavalent Vaccine Sales by Type (2021-2026)
6.3 APAC Pentavalent Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pentavalent Vaccine by Country
7.1.1 Europe Pentavalent Vaccine Sales by Country (2021-2026)
7.1.2 Europe Pentavalent Vaccine Revenue by Country (2021-2026)
7.2 Europe Pentavalent Vaccine Sales by Type (2021-2026)
7.3 Europe Pentavalent Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pentavalent Vaccine by Country
8.1.1 Middle East & Africa Pentavalent Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pentavalent Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Pentavalent Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Pentavalent Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pentavalent Vaccine
10.3 Manufacturing Process Analysis of Pentavalent Vaccine
10.4 Industry Chain Structure of Pentavalent Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pentavalent Vaccine Distributors
11.3 Pentavalent Vaccine Customer
12 WORLD FORECAST REVIEW FOR PENTAVALENT VACCINE BY GEOGRAPHIC REGION
12.1 Global Pentavalent Vaccine Market Size Forecast by Region
12.1.1 Global Pentavalent Vaccine Forecast by Region (2027-2032)
12.1.2 Global Pentavalent Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pentavalent Vaccine Forecast by Type (2027-2032)
12.7 Global Pentavalent Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Serum Institute of India
13.1.1 Serum Institute of India Company Information
13.1.2 Serum Institute of India Pentavalent Vaccine Product Portfolios and Specifications
13.1.3 Serum Institute of India Pentavalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Serum Institute of India Main Business Overview
13.1.5 Serum Institute of India Latest Developments
13.2 Panacea Drugs Pvt. Ltd
13.2.1 Panacea Drugs Pvt. Ltd Company Information
13.2.2 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product Portfolios and Specifications
13.2.3 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Panacea Drugs Pvt. Ltd Main Business Overview
13.2.5 Panacea Drugs Pvt. Ltd Latest Developments
13.3 Shantha Biotechnics
13.3.1 Shantha Biotechnics Company Information
13.3.2 Shantha Biotechnics Pentavalent Vaccine Product Portfolios and Specifications
13.3.3 Shantha Biotechnics Pentavalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Shantha Biotechnics Main Business Overview
13.3.5 Shantha Biotechnics Latest Developments
13.4 Biological E. Ltd.
13.4.1 Biological E. Ltd. Company Information
13.4.2 Biological E. Ltd. Pentavalent Vaccine Product Portfolios and Specifications
13.4.3 Biological E. Ltd. Pentavalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Biological E. Ltd. Main Business Overview
13.4.5 Biological E. Ltd. Latest Developments
13.5 Novartis AG
13.5.1 Novartis AG Company Information
13.5.2 Novartis AG Pentavalent Vaccine Product Portfolios and Specifications
13.5.3 Novartis AG Pentavalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Novartis AG Main Business Overview
13.5.5 Novartis AG Latest Developments
13.6 Crucell
13.6.1 Crucell Company Information
13.6.2 Crucell Pentavalent Vaccine Product Portfolios and Specifications
13.6.3 Crucell Pentavalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Crucell Main Business Overview
13.6.5 Crucell Latest Developments
13.7 Bio Farma
13.7.1 Bio Farma Company Information
13.7.2 Bio Farma Pentavalent Vaccine Product Portfolios and Specifications
13.7.3 Bio Farma Pentavalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Bio Farma Main Business Overview
13.7.5 Bio Farma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pentavalent Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pentavalent Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Lyophilized
Table 4. Major Players of Liquid
Table 5. Global Pentavalent Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Pentavalent Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Pentavalent Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Pentavalent Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Pentavalent Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Pentavalent Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Pentavalent Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Pentavalent Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Pentavalent Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Pentavalent Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Pentavalent Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Pentavalent Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Pentavalent Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Pentavalent Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Pentavalent Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Pentavalent Vaccine Producing Area Distribution and Sales Area
Table 21. Players Pentavalent Vaccine Products Offered
Table 22. Pentavalent Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pentavalent Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Pentavalent Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Pentavalent Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Pentavalent Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Pentavalent Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Pentavalent Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Pentavalent Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Pentavalent Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Pentavalent Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Pentavalent Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Pentavalent Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Pentavalent Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Pentavalent Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Pentavalent Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Pentavalent Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Pentavalent Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Pentavalent Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Pentavalent Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Pentavalent Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Pentavalent Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Pentavalent Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Pentavalent Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Pentavalent Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Pentavalent Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Pentavalent Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Pentavalent Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Pentavalent Vaccine
Table 52. Key Market Challenges & Risks of Pentavalent Vaccine
Table 53. Key Industry Trends of Pentavalent Vaccine
Table 54. Pentavalent Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pentavalent Vaccine Distributors List
Table 57. Pentavalent Vaccine Customer List
Table 58. Global Pentavalent Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Pentavalent Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Pentavalent Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Pentavalent Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Pentavalent Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Pentavalent Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Pentavalent Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Pentavalent Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Pentavalent Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Pentavalent Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Pentavalent Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Pentavalent Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Pentavalent Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Pentavalent Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Serum Institute of India Basic Information, Pentavalent Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Serum Institute of India Pentavalent Vaccine Product Portfolios and Specifications
Table 74. Serum Institute of India Pentavalent Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Serum Institute of India Main Business
Table 76. Serum Institute of India Latest Developments
Table 77. Panacea Drugs Pvt. Ltd Basic Information, Pentavalent Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product Portfolios and Specifications
Table 79. Panacea Drugs Pvt. Ltd Pentavalent Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Panacea Drugs Pvt. Ltd Main Business
Table 81. Panacea Drugs Pvt. Ltd Latest Developments
Table 82. Shantha Biotechnics Basic Information, Pentavalent Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Shantha Biotechnics Pentavalent Vaccine Product Portfolios and Specifications
Table 84. Shantha Biotechnics Pentavalent Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Shantha Biotechnics Main Business
Table 86. Shantha Biotechnics Latest Developments
Table 87. Biological E. Ltd. Basic Information, Pentavalent Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Biological E. Ltd. Pentavalent Vaccine Product Portfolios and Specifications
Table 89. Biological E. Ltd. Pentavalent Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Biological E. Ltd. Main Business
Table 91. Biological E. Ltd. Latest Developments
Table 92. Novartis AG Basic Information, Pentavalent Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Novartis AG Pentavalent Vaccine Product Portfolios and Specifications
Table 94. Novartis AG Pentavalent Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Novartis AG Main Business
Table 96. Novartis AG Latest Developments
Table 97. Crucell Basic Information, Pentavalent Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Crucell Pentavalent Vaccine Product Portfolios and Specifications
Table 99. Crucell Pentavalent Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Crucell Main Business
Table 101. Crucell Latest Developments
Table 102. Bio Farma Basic Information, Pentavalent Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Bio Farma Pentavalent Vaccine Product Portfolios and Specifications
Table 104. Bio Farma Pentavalent Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Bio Farma Main Business
Table 106. Bio Farma Latest Developments
Table 1. Pentavalent Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pentavalent Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Lyophilized
Table 4. Major Players of Liquid
Table 5. Global Pentavalent Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Pentavalent Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Pentavalent Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Pentavalent Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Pentavalent Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Pentavalent Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Pentavalent Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Pentavalent Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Pentavalent Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Pentavalent Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Pentavalent Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Pentavalent Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Pentavalent Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Pentavalent Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Pentavalent Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Pentavalent Vaccine Producing Area Distribution and Sales Area
Table 21. Players Pentavalent Vaccine Products Offered
Table 22. Pentavalent Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pentavalent Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Pentavalent Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Pentavalent Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Pentavalent Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Pentavalent Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Pentavalent Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Pentavalent Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Pentavalent Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Pentavalent Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Pentavalent Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Pentavalent Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Pentavalent Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Pentavalent Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Pentavalent Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Pentavalent Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Pentavalent Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Pentavalent Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Pentavalent Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Pentavalent Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Pentavalent Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Pentavalent Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Pentavalent Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Pentavalent Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Pentavalent Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Pentavalent Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Pentavalent Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Pentavalent Vaccine
Table 52. Key Market Challenges & Risks of Pentavalent Vaccine
Table 53. Key Industry Trends of Pentavalent Vaccine
Table 54. Pentavalent Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pentavalent Vaccine Distributors List
Table 57. Pentavalent Vaccine Customer List
Table 58. Global Pentavalent Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Pentavalent Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Pentavalent Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Pentavalent Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Pentavalent Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Pentavalent Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Pentavalent Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Pentavalent Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Pentavalent Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Pentavalent Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Pentavalent Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Pentavalent Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Pentavalent Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Pentavalent Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Serum Institute of India Basic Information, Pentavalent Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Serum Institute of India Pentavalent Vaccine Product Portfolios and Specifications
Table 74. Serum Institute of India Pentavalent Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Serum Institute of India Main Business
Table 76. Serum Institute of India Latest Developments
Table 77. Panacea Drugs Pvt. Ltd Basic Information, Pentavalent Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product Portfolios and Specifications
Table 79. Panacea Drugs Pvt. Ltd Pentavalent Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Panacea Drugs Pvt. Ltd Main Business
Table 81. Panacea Drugs Pvt. Ltd Latest Developments
Table 82. Shantha Biotechnics Basic Information, Pentavalent Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Shantha Biotechnics Pentavalent Vaccine Product Portfolios and Specifications
Table 84. Shantha Biotechnics Pentavalent Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Shantha Biotechnics Main Business
Table 86. Shantha Biotechnics Latest Developments
Table 87. Biological E. Ltd. Basic Information, Pentavalent Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Biological E. Ltd. Pentavalent Vaccine Product Portfolios and Specifications
Table 89. Biological E. Ltd. Pentavalent Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Biological E. Ltd. Main Business
Table 91. Biological E. Ltd. Latest Developments
Table 92. Novartis AG Basic Information, Pentavalent Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Novartis AG Pentavalent Vaccine Product Portfolios and Specifications
Table 94. Novartis AG Pentavalent Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Novartis AG Main Business
Table 96. Novartis AG Latest Developments
Table 97. Crucell Basic Information, Pentavalent Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Crucell Pentavalent Vaccine Product Portfolios and Specifications
Table 99. Crucell Pentavalent Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Crucell Main Business
Table 101. Crucell Latest Developments
Table 102. Bio Farma Basic Information, Pentavalent Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Bio Farma Pentavalent Vaccine Product Portfolios and Specifications
Table 104. Bio Farma Pentavalent Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Bio Farma Main Business
Table 106. Bio Farma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pentavalent Vaccine
Figure 2. Pentavalent Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pentavalent Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Pentavalent Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pentavalent Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pentavalent Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Pentavalent Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Lyophilized
Figure 12. Product Picture of Liquid
Figure 13. Global Pentavalent Vaccine Sales Market Share by Type in 2026
Figure 14. Global Pentavalent Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Pentavalent Vaccine Consumed in Retail Pharmacy
Figure 16. Global Pentavalent Vaccine Market: Retail Pharmacy (2021-2026) & (K Units)
Figure 17. Pentavalent Vaccine Consumed in Hospital Pharmacy
Figure 18. Global Pentavalent Vaccine Market: Hospital Pharmacy (2021-2026) & (K Units)
Figure 19. Pentavalent Vaccine Consumed in E-commerce
Figure 20. Global Pentavalent Vaccine Market: E-commerce (2021-2026) & (K Units)
Figure 21. Global Pentavalent Vaccine Sale Market Share by Application (2025)
Figure 22. Global Pentavalent Vaccine Revenue Market Share by Application in 2026
Figure 23. Pentavalent Vaccine Sales by Company in 2026 (K Units)
Figure 24. Global Pentavalent Vaccine Sales Market Share by Company in 2026
Figure 25. Pentavalent Vaccine Revenue by Company in 2026 ($ millions)
Figure 26. Global Pentavalent Vaccine Revenue Market Share by Company in 2026
Figure 27. Global Pentavalent Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Pentavalent Vaccine Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Pentavalent Vaccine Sales 2021-2026 (K Units)
Figure 30. Americas Pentavalent Vaccine Revenue 2021-2026 ($ millions)
Figure 31. APAC Pentavalent Vaccine Sales 2021-2026 (K Units)
Figure 32. APAC Pentavalent Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Europe Pentavalent Vaccine Sales 2021-2026 (K Units)
Figure 34. Europe Pentavalent Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Pentavalent Vaccine Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Pentavalent Vaccine Revenue 2021-2026 ($ millions)
Figure 37. Americas Pentavalent Vaccine Sales Market Share by Country in 2026
Figure 38. Americas Pentavalent Vaccine Revenue Market Share by Country (2021-2026)
Figure 39. Americas Pentavalent Vaccine Sales Market Share by Type (2021-2026)
Figure 40. Americas Pentavalent Vaccine Sales Market Share by Application (2021-2026)
Figure 41. United States Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Pentavalent Vaccine Sales Market Share by Region in 2026
Figure 46. APAC Pentavalent Vaccine Revenue Market Share by Region (2021-2026)
Figure 47. APAC Pentavalent Vaccine Sales Market Share by Type (2021-2026)
Figure 48. APAC Pentavalent Vaccine Sales Market Share by Application (2021-2026)
Figure 49. China Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. India Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Pentavalent Vaccine Sales Market Share by Country in 2026
Figure 57. Europe Pentavalent Vaccine Revenue Market Share by Country (2021-2026)
Figure 58. Europe Pentavalent Vaccine Sales Market Share by Type (2021-2026)
Figure 59. Europe Pentavalent Vaccine Sales Market Share by Application (2021-2026)
Figure 60. Germany Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. France Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Pentavalent Vaccine Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Pentavalent Vaccine Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Pentavalent Vaccine Sales Market Share by Application (2021-2026)
Figure 68. Egypt Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Pentavalent Vaccine in 2026
Figure 74. Manufacturing Process Analysis of Pentavalent Vaccine
Figure 75. Industry Chain Structure of Pentavalent Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Pentavalent Vaccine Sales Market Forecast by Region (2027-2032)
Figure 78. Global Pentavalent Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Pentavalent Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Pentavalent Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Pentavalent Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Pentavalent Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Pentavalent Vaccine
Figure 2. Pentavalent Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pentavalent Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Pentavalent Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pentavalent Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pentavalent Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Pentavalent Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Lyophilized
Figure 12. Product Picture of Liquid
Figure 13. Global Pentavalent Vaccine Sales Market Share by Type in 2026
Figure 14. Global Pentavalent Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Pentavalent Vaccine Consumed in Retail Pharmacy
Figure 16. Global Pentavalent Vaccine Market: Retail Pharmacy (2021-2026) & (K Units)
Figure 17. Pentavalent Vaccine Consumed in Hospital Pharmacy
Figure 18. Global Pentavalent Vaccine Market: Hospital Pharmacy (2021-2026) & (K Units)
Figure 19. Pentavalent Vaccine Consumed in E-commerce
Figure 20. Global Pentavalent Vaccine Market: E-commerce (2021-2026) & (K Units)
Figure 21. Global Pentavalent Vaccine Sale Market Share by Application (2025)
Figure 22. Global Pentavalent Vaccine Revenue Market Share by Application in 2026
Figure 23. Pentavalent Vaccine Sales by Company in 2026 (K Units)
Figure 24. Global Pentavalent Vaccine Sales Market Share by Company in 2026
Figure 25. Pentavalent Vaccine Revenue by Company in 2026 ($ millions)
Figure 26. Global Pentavalent Vaccine Revenue Market Share by Company in 2026
Figure 27. Global Pentavalent Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Pentavalent Vaccine Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Pentavalent Vaccine Sales 2021-2026 (K Units)
Figure 30. Americas Pentavalent Vaccine Revenue 2021-2026 ($ millions)
Figure 31. APAC Pentavalent Vaccine Sales 2021-2026 (K Units)
Figure 32. APAC Pentavalent Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Europe Pentavalent Vaccine Sales 2021-2026 (K Units)
Figure 34. Europe Pentavalent Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Pentavalent Vaccine Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Pentavalent Vaccine Revenue 2021-2026 ($ millions)
Figure 37. Americas Pentavalent Vaccine Sales Market Share by Country in 2026
Figure 38. Americas Pentavalent Vaccine Revenue Market Share by Country (2021-2026)
Figure 39. Americas Pentavalent Vaccine Sales Market Share by Type (2021-2026)
Figure 40. Americas Pentavalent Vaccine Sales Market Share by Application (2021-2026)
Figure 41. United States Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Pentavalent Vaccine Sales Market Share by Region in 2026
Figure 46. APAC Pentavalent Vaccine Revenue Market Share by Region (2021-2026)
Figure 47. APAC Pentavalent Vaccine Sales Market Share by Type (2021-2026)
Figure 48. APAC Pentavalent Vaccine Sales Market Share by Application (2021-2026)
Figure 49. China Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. India Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Pentavalent Vaccine Sales Market Share by Country in 2026
Figure 57. Europe Pentavalent Vaccine Revenue Market Share by Country (2021-2026)
Figure 58. Europe Pentavalent Vaccine Sales Market Share by Type (2021-2026)
Figure 59. Europe Pentavalent Vaccine Sales Market Share by Application (2021-2026)
Figure 60. Germany Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. France Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Pentavalent Vaccine Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Pentavalent Vaccine Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Pentavalent Vaccine Sales Market Share by Application (2021-2026)
Figure 68. Egypt Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Pentavalent Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Pentavalent Vaccine in 2026
Figure 74. Manufacturing Process Analysis of Pentavalent Vaccine
Figure 75. Industry Chain Structure of Pentavalent Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Pentavalent Vaccine Sales Market Forecast by Region (2027-2032)
Figure 78. Global Pentavalent Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Pentavalent Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Pentavalent Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Pentavalent Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Pentavalent Vaccine Revenue Market Share Forecast by Application (2027-2032)
